An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy.
Chaudhry
Vinay
V
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. vchaudh@jhmi.edu
Cornblath
David R
DR
D000328:Adult; D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D004185:Disability Evaluation; D005260:Female; D005500:Follow-Up Studies; D018737:Hand Strength / Q000502:physiology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011115:Polyneuropathies / Q000276:immunology* / Q000503:physiopathology / Q000628:therapy*; D000069283:Rituximab; D013997:Time Factors; D016896:Treatment Outcome
D058846:Antibodies, Monoclonal, Murine-Derived; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D000069283:Rituximab